CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
Background Lung adenocarcinoma (ACA) is the most common subtype of non-small-cell lung cancer. About 70%–80% patients are diagnosed at an advanced stage; therefore, the survival rate is poor. It is urgent to discover accurate markers that can differentiate the late stages of lung ACA from the early...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
PeerJ Inc.
2020-10-01
|
| Series: | PeerJ |
| Assuntos: | |
| Acceso en liña: | https://peerj.com/articles/10126.pdf |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|